The OS plot revealed that a high OTUD6B level was significantly linked to shorter OS times in patients with KICH, BRCA, GBM, UVM, LGG, LUAD, SRAC, MESO, and LIHC, and a better clinical outcome was observed in patients with KIRC (Figure 5A). This evidence concerns the gene OTUD6B and glioblastoma.